Suzane  Kioko Ono
Suzane Kioko Ono
Professor Livre-Docente, Departamento de Gastroenterologia, Universidade de São Paulo
Verified email at
Cited by
Cited by
Nomenclature for antiviral resistant human hepatitis B virus mutations in the polymerase region
LJ Stuyver, SA Locarnini, A Lok, DD Richman, WF Carman, JL Dienstag, ...
Frontiers in Viral Hepatitis, 335-351, 2003
The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
SK Ono, N Kato, Y Shiratori, J Kato, T Goto, RF Schinazi, FJ Carrilho, ...
The Journal of clinical investigation 107 (4), 449-455, 2001
Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer
N Kato, H Yoshida, SK Ono-Nita, J Kato, T Goto, M Otsuka, K Lan, ...
Hepatology 32 (2), 405-412, 2000
YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection
SK Ono‐Nita, N Kato, Y Shiratori, T Masaki, KH Lan, FJ Carrilho, M Omata
Hepatology 29 (3), 939-945, 1999
Hepatitis C Virus Nonstructural Region 5A Protein: A Potent Transcriptional Activator
N Kato, KH Lan, SK Ono-Nita, H Yoshida, Y Shiratori, M Omata
HCV and Related Liver Diseases, 45-58, 1999
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors
SK Ono-Nita, N Kato, Y Shiratori, KH Lan, H Yoshida, FJ Carrilho, ...
The Journal of clinical investigation 103 (12), 1635-1640, 1999
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo
J Kato, N Kato, H Yoshida, SK Ono‐Nita, Y Shiratori, M Omata
Journal of medical virology 66 (2), 187-199, 2002
Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide
ND Shah, M Ventura-Cots, JG Abraldes, M Alboraie, A Alfadhli, J Argemi, ...
Clinical Gastroenterology and Hepatology 17 (11), 2320-2329. e12, 2019
Avaliação de tecnologia em saúde: II. A análise de custo-efetividade
SR Secoli, ME Nita, SK Ono-Nita, M Nobre
Arquivos de Gastroenterologia 47, 329-333, 2010
Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Y Shiratori, S Shiina, PY Zhang, E Ohno, T Okudaira, DA Payawal, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1997
Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort
DC Paranaguá-Vezozzo, SK Ono, MV Alvarado-Mora, AQ Farias, ...
Annals of hepatology 13 (4), 386-393, 2014
Avaliação de tecnologias em saúde: evidência clínica, análise econômica e análise de decisão
ME Nita, SR Secoli, MRC Nobre, SK Ono-Nita, ACC Campino, FM Sarti, ...
Avaliação de tecnologias em saúde: evidência clínica, análise econômica e …, 2010
Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus
SK Ono-Nita, N Kato, Y Shiratori, FJ Carrilho, M Omata
Antimicrobial Agents and Chemotherapy 46 (8), 2602-2605, 2002
Pegylated interferon alfa for chronic hepatitis B: systematic review and meta‐analysis
V Kim, RM Abreu, DM Nakagawa, RM Baldassare, FJ Carrilho, SK Ono
Journal of Viral Hepatitis 23 (3), 154-169, 2016
Molecular aspects of hepatic carcinogenesis
NM Eidi, AVA Ferreira, ONONS CARRILHO Flair José, MES Kioko, ...
Revista do Instituto de Medicina Tropical de São Paulo 44, 2002
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients
JA Nogueira, SK Ono-Nita, ME Nita, MMT de Souza, EP do Carmo, ...
BMC cancer 9, 1-8, 2009
Bcl‐XL Antisense Sensitizes Human Colon Cancer Cell Line to 5‐Fluorouracil
ME Nita, SK Ono‐Nita, N Tsuno, O Tominaga, T Takenoue, E Sunami, ...
Japanese journal of cancer research 91 (8), 825-832, 2000
Métodos de pesquisa em avaliação de tecnologia em saúde
ME Nita, SR Secoli, M Nobre, SK Ono-Nita
Arquivos de Gastroenterologia 46, 252-255, 2009
Large isoform of hepatitis delta antigen activates serum response factor-associated transcription
T Goto, N Kato, SK Ono-Nita, H Yoshida, M Otsuka, Y Shiratori, M Omata
Journal of Biological Chemistry 275 (48), 37311-37316, 2000
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B
T Piratvisuth, P Komolmit, T Tanwandee, W Sukeepaisarnjaroen, ...
PloS one 8 (2), e54279, 2013
The system can't perform the operation now. Try again later.
Articles 1–20